Rechallenge with oxaliplatin and peripheral neuropathy in colorectal cancer patients.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Oxaliplatin (OXA) is a cornerstone in the treatment of colorectal cancer (CRC). Retreatment with OXA is frequently considered as salvage treatment. OXA-induced neuropathy (OIN) is the most frequent and feared long-term side effect.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Cancer Res Clin Oncol

Title: Journal of cancer research and clinical oncology

Publisher: Springer Science and Business Media LLC

ISSN (Electronic): 1432-1335

ISSN (Print): 0171-5216

Publication date (Electronic): Sep 2018

Volume: 144

Issue: 9

Affiliations

[1 ] Neuro-Oncology Unit, Neurology Department, Hospital Universitari de Bellvitge-Institut Català d´Oncologia-IDIBELL, C/Feixa Llarga s/n, L´Hospitalet de Llobregat, 08907, Barcelona, Spain.

[2 ] Neurology Department, Hospital Universitari Mútua de Terrassa, Terrassa, Barcelona, Spain.

[3 ] Medical Oncology Department, Institut Català d´Oncologia-IDIBELL, CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain.

[4 ] Service de Neuro-Oncologie, Hospices Civils de Lyon, Groupe Hospitalier Est, Lyon Cedex, France.

[5 ] Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences, Universitat Autònoma de Barcelona, and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Bellaterra, Spain.

[6 ] Neuro-Oncology Unit, Neurology Department, Hospital Universitari de Bellvitge-Institut Català d´Oncologia-IDIBELL, C/Feixa Llarga s/n, L´Hospitalet de Llobregat, 08907, Barcelona, Spain. rvelascof@bellvitgehospital.cat.

[7 ] Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences, Universitat Autònoma de Barcelona, and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Bellaterra, Spain. rvelascof@bellvitgehospital.cat.

Article

Publisher Item ID: 10.1007/s00432-018-2691-8

DOI: 10.1007/s00432-018-2691-8

PubMed ID: 29955956

SO-VID: 53f1d18f-a008-4281-8faa-c57d249009de

History

Keywords: Neurotoxicity,FOLFOX,Oxaliplatin,Oxaliplatin-induced neuropathy,Retreatment

Data availability:

Keywords: Neurotoxicity, FOLFOX, Oxaliplatin, Oxaliplatin-induced neuropathy, Retreatment

Rechallenge with oxaliplatin and peripheral neuropathy in colorectal cancer patients.

Read this article at

Abstract

Related collections

Cancer Metabolism

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 600

Cited by 12